Information for "Retifanlimab"
Basic information
| Display title | Retifanlimab |
| Default sort key | Retifanlimab |
| Page length (in bytes) | 9,153 |
| Namespace ID | 0 |
| Page ID | 73360286 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Wikidata item ID | Q117349369 |
| Local description | Medication |
| Central description | monoclonal antibody |
| Page views in the past 30 days |
Page protection
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
Edit history
| Page creator | Whywhenwhohow (talk | contribs) |
| Date of page creation | 05:37, 23 March 2023 |
| Latest editor | Whywhenwhohow (talk | contribs) |
| Date of latest edit | 01:46, 18 May 2024 |
| Total number of edits | 12 |
| Recent number of edits (within past 30 days) | 2 |
| Recent number of distinct authors | 1 |